Reported Jan 11, 2023 · Terminated

Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial,…

Pine Pharmaceuticals, LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Pine Pharmaceuticals, LLC · 355 Riverwalk Pkwy · Tonawanda, NY · 14150-5837

Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1

Lot codes and dates: Lot # 62881
Exp 12/25/2022
62923
Exp 12/26/2022
63066
Exp 01/03/2023
63067
Exp 01/01/2023
63103
Exp 01/02/2023
63120
Exp 01/03/2023
63219
63226
Exp 01/08/2023
63263
Exp 01/09/2023
63380
63381
Exp 01/15/2023
63433
Exp 01/16/2023
63455
Exp 01/17/2023
63537
Exp 01/22/2023
63580
Exp 01/23/2023
63721
Exp 01/29/2023
63792
Exp 01/31/2023
63888
Exp 02/05/2023
63930
Exp 02/06/2023
63959
Exp 02/07/2023
64079
Exp 02/13/2023
64109
Exp 02/14/2023
64239
Exp 02/21/2023
Amount recalled: 11,453 vials

CGMP Deviations: Raw material recalled by repackager, due to discoloration.

This product could cause temporary or reversible health problems — stop using it.

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.